HCW Biologics announces 1-for-6 reverse stock split effective June 30, 2026 to maintain Nasdaq listing

HCW Biologics Inc.

Board approved 1-for-6 reverse split; effective 12:01 a.m. ET June 30, 2026; symbol HCWB unchanged.
Outstanding shares reduce from ~9.58M to ~1.60M; total authorized shares remain 250M.
Nasdaq Hearings Panel required 20 consecutive trading days >$1.00 by July 29; company met that on June 12.
Split intended to ensure continued compliance with Bid Price Rule and Panel conditions; CUSIP changes to 40423R303.
No fractional shares issued; each holder receiving a fractional share instead gets one whole share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.